Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$0.46
+1.1%
C$0.48
C$0.45
C$0.66
C$8.47M1.6916,954 shs4,500 shs
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$0.08
C$0.07
C$0.06
C$0.12
C$31.13M0.88302,628 shs177,183 shs
Meta Platforms, Inc. stock logo
META
Meta Platforms
$747.38
-0.9%
$732.47
$479.80
$796.25
$1.88T1.2715.09 million shs8.25 million shs
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
C$0.17
-2.9%
C$0.21
C$0.04
C$0.36
C$25M0.32200,211 shs166,000 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
+1.10%-2.13%-2.13%-8.00%-31.34%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00%0.00%+7.14%0.00%+15.38%
Meta Platforms, Inc. stock logo
META
Meta Platforms
+0.11%+0.35%+5.81%+17.17%+44.71%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00%+9.68%-8.11%0.00%+277.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/AN/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
4.6259 of 5 stars
3.54.01.70.04.03.32.5
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00
N/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00
N/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
2.96
Moderate Buy$822.4110.00% Upside
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CTX, META, LABS, and VM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/19/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/13/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$920.00
8/5/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$888.00 ➝ $980.00
8/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$640.00 ➝ $810.00
7/31/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
7/31/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/31/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$650.00 ➝ $825.00
7/31/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$610.00 ➝ $900.00
7/31/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$675.00 ➝ $685.00
7/31/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$845.00 ➝ $900.00
(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$16.62M0.51C$0.38 per share1.20C$0.83 per share0.55
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$39.42M0.79C$0.06 per share1.30C$0.11 per share0.68
Meta Platforms, Inc. stock logo
META
Meta Platforms
$164.50B11.42$30.50 per share24.51$77.65 per share9.63
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AC$0.00 per share35.00C$0.01 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
-C$2.61M-C$0.15N/AN/A-15.73%-15.60%-8.26%N/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
-C$12.05M-C$0.03N/AN/A-30.56%-24.41%-7.17%N/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$62.36B$27.6227.0724.751.5639.99%39.33%25.83%10/29/2025 (Estimated)
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-C$1.66M-C$0.01N/AN/AN/A-117.77%-30.77%N/A

Latest CTX, META, LABS, and VM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
$5.75$7.14+$1.39$7.14$44.55 billion$47.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$2.100.28%N/A7.60%1 Years
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/A

Latest CTX, META, LABS, and VM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/29/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
quarterly$0.52500.33%6/16/20256/16/20256/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
5.77
2.70
2.29
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
1.45
3.21
3.10
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.15
1.97
1.97
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
4.23
0.10
0.84

Institutional Ownership

CompanyInstitutional Ownership
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.71%
Meta Platforms, Inc. stock logo
META
Meta Platforms
79.91%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
10.87%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
4.45%
Meta Platforms, Inc. stock logo
META
Meta Platforms
13.61%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
10.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
6218.41 millionN/ANot Optionable
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
130415.00 millionN/ANot Optionable
Meta Platforms, Inc. stock logo
META
Meta Platforms
74,0672.51 billion2.17 billionOptionable
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A151.52 millionN/ANot Optionable

Recent News About These Companies

Canadian Investment Regulatory Organization Trading Halt - VM
Voyageur Pharmaceuticals Ltd (VM)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Crescita Therapeutics stock logo

Crescita Therapeutics TSE:CTX

C$0.46 +0.01 (+1.10%)
As of 11:13 AM Eastern

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

MediPharm Labs stock logo

MediPharm Labs TSE:LABS

C$0.08 0.00 (0.00%)
As of 03:59 PM Eastern

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.

Meta Platforms stock logo

Meta Platforms NASDAQ:META

$747.38 -6.72 (-0.89%)
Closing price 04:00 PM Eastern
Extended Trading
$744.47 -2.91 (-0.39%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California

Voyageur Pharmaceuticals stock logo

Voyageur Pharmaceuticals CVE:VM

C$0.16 -0.01 (-2.94%)
As of 03:58 PM Eastern

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.